Pradaxa lawsuits may be filed by patients who took the blood thinner and subsequently suffered from internal bleeding side effects. Contact a lawyer today if you believe you have been affected by the medication.
Pradaxa was introduced to the U.S. market in October 2010 by drug maker Boehringer Ingelheim as a preventative measure against blood clots and stroke in patients diagnosed with non-valvular atrial fibrillation. Unfortunately, before Pradaxa was even on the market for a year, reports emerged concerning possible internal bleeding side effects associated with the blood thinner. Despite its reputation as the first drug to rival Warfarin, a popular anticoagulant that has been available in the U.S. since 1954, new information about potentially fatal side effects linked to Pradaxa has raised serious concerns about the safety of the blood thinner. If you took Pradaxa and have since experienced a major side effect like internal bleeding, contact our qualified attorneys at Oklahoma Legal Center today.
Non-valvular atrial fibrillation describes a heart rhythm abnormality in which part of the heart doesn’t beat properly. Although atrial fibrillation, also known as A-fib, may cause no symptoms, it is often linked to chest pain, palpitations, fainting, or congestive heart failure. Atrial fibrillation also increases the risk of stroke, possibly up to seven times that of the average population, depending on the presence of additional risk factors like high blood pressure. Patients diagnosed with non-valvular atrial fibrillation may take Pradaxa in hopes that the blood thinner will effectively treat their condition without exposing them to any unnecessary harm. Unfortunately, just by taking the drug, they may be exposing themselves to potentially life-threatening side effects.
Internal Bleeding Complications Linked to Pradaxa
In September 2011, a Pradaxa investigation was launched by drug regulators in New Zealand after five elderly patients taking the blood thinner died due to internal bleeding or hemorrhaging. Prior to this investigation, regulators in Japan sent a letter to Boehringer Ingelheim, suggesting that the company warn healthcare professionals about possible side effects, including internal bleeding and death. According to the letter, 81 elderly patients suffered heavy bleeding or hemorrhaging associated with Pradaxa over a five-month period. The FDA finally issued a Pradaxa warning in December 2011, indicating that the agency was conducting its own investigation regarding post-marketing reports of serious bleeding events in Pradaxa patients.
Contact Our Reputable Attorneys for Help
In addition to potentially fatal internal bleeding, the blood thinner Pradaxa may also be linked to serious side effects like heart disease and heart attack. If you or a loved one has suffered from a major side effect, which you believe to be associated with the anticoagulant Pradaxa, contact our experienced attorneys at Oklahoma Legal Center for legal help. You may have grounds to file a lawsuit against Boehringer Ingelheim, in order to seek financial compensation for your medical bills, injuries, and pain and suffering. By hiring a qualified lawyer to represent your case, you can protect your legal rights and bring public attention to the dangers of some pharmaceutical drugs.